Literature DB >> 10191236

A large outbreak of hemolytic uremic syndrome caused by an unusual sorbitol-fermenting strain of Escherichia coli O157:H-.

A Ammon1, L R Petersen, H Karch.   

Abstract

Escherichia coli O157:H7 does not ferment sorbitol, a factor used to differentiate it from other E. coli. From December 1995 to March 1996, 28 children with hemolytic uremic syndrome in Bavaria, Germany, were identified; many had a sorbitol-fermenting (sf) E. coli O157:H- cultured. A case-control study showed a dose-response relationship between sausage consumption and illness. A second case-control study showed a relationship between mortadella and teewurst consumption and illness, particularly during December (mortadella odds ratio [OR], 10.5, P=.004; teewurst OR, 6.2, P=.02). Twelve sf O157:H- were characterized to determine clonality and virulence traits. The strains possessed the Stx2, eae, and EHEC-hlyA genes but were nonhemolytic on blood agar plates. The O157:H- isolates belonged to phage type 88 and had identical pulsed-field gel electrophoresis patterns. This outbreak was caused by sf E. coli O157:H-, which is not detectable by culture on sorbitol MacConkey's agar. Consumption of two sausages, including a raw beef-containing sausage, was statistically related to illness.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10191236     DOI: 10.1086/314715

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  36 in total

1.  Phage types and genotypes of Shiga toxin-Producing Escherichia coli O157 in Finland.

Authors:  M Saari; T Cheasty; K Leino; A Siitonen
Journal:  J Clin Microbiol       Date:  2001-03       Impact factor: 5.948

Review 2.  Sorbitol-fermenting Shiga toxin-producing Escherichia coli O157:H(-) strains: epidemiology, phenotypic and molecular characteristics, and microbiological diagnosis.

Authors:  H Karch; M Bielaszewska
Journal:  J Clin Microbiol       Date:  2001-06       Impact factor: 5.948

Review 3.  Molecular mechanisms that mediate colonization of Shiga toxin-producing Escherichia coli strains.

Authors:  Mauricio J Farfan; Alfredo G Torres
Journal:  Infect Immun       Date:  2011-12-05       Impact factor: 3.441

4.  Evaluation of BBL CHROMagar O157 versus sorbitol-MacConkey medium for routine detection of Escherichia coli O157 in a centralized regional clinical microbiology laboratory.

Authors:  D L Church; D Emshey; H Semeniuk; T Lloyd; J D Pitout
Journal:  J Clin Microbiol       Date:  2007-07-18       Impact factor: 5.948

5.  Prevalences of Shiga toxin subtypes and selected other virulence factors among Shiga-toxigenic Escherichia coli strains isolated from fresh produce.

Authors:  Peter C H Feng; Shanker Reddy
Journal:  Appl Environ Microbiol       Date:  2013-08-30       Impact factor: 4.792

6.  Presence and characterization of a mosaic genomic island which distinguishes sorbitol-fermenting enterohemorrhagic Escherichia coli O157:H- from E. coli O157:H7.

Authors:  Andreas Janka; Georg Becker; Anne-Katharina Sonntag; Martina Bielaszewska; Ulrich Dobrindt; Helge Karch
Journal:  Appl Environ Microbiol       Date:  2005-08       Impact factor: 4.792

7.  Recycling of Shiga toxin 2 genes in sorbitol-fermenting enterohemorrhagic Escherichia coli O157:NM.

Authors:  Alexander Mellmann; Shan Lu; Helge Karch; Jian-guo Xu; Dag Harmsen; M Alexander Schmidt; Martina Bielaszewska
Journal:  Appl Environ Microbiol       Date:  2007-11-02       Impact factor: 4.792

8.  Differences in levels of secreted locus of enterocyte effacement proteins between human disease-associated and bovine Escherichia coli O157.

Authors:  A McNally; A J Roe; S Simpson; F M Thomson-Carter; D E Hoey; C Currie; T Chakraborty; D G Smith; D L Gally
Journal:  Infect Immun       Date:  2001-08       Impact factor: 3.441

9.  Pathogenic potential of emergent sorbitol-fermenting Escherichia coli O157:NM.

Authors:  Tracy Rosser; Tracy Dransfield; Lesley Allison; Mary Hanson; Nicola Holden; Judith Evans; Stuart Naylor; Roberto La Ragione; J Christopher Low; David L Gally
Journal:  Infect Immun       Date:  2008-10-13       Impact factor: 3.441

10.  Developing national epidemiologic capacity to meet the challenges of emerging infections in Germany.

Authors:  L R Petersen; A Ammon; O Hamouda; T Breuer; S Kiessling; B Bellach; U Niemer; F J Bindert; S Ostroff; R Kurth
Journal:  Emerg Infect Dis       Date:  2000 Nov-Dec       Impact factor: 6.883

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.